Filing Details

Accession Number:
0001209191-16-128681
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-17 18:00:56
Reporting Period:
2016-06-15
Filing Date:
2016-06-17
Accepted Time:
2016-06-17 18:00:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1330401 Jason Hannon 7475 Lusk Blvd
San Diego CA 92121
Evp, International No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-15 2,231 $26.62 37,616 No 4 M Direct
Common Stock Acquisiton 2016-06-15 47,769 $26.62 85,385 No 4 M Direct
Common Stock Disposition 2016-06-15 35,466 $57.69 49,919 No 4 F Direct
Common Stock Disposition 2016-06-15 2,231 $58.42 47,688 No 4 S Direct
Common Stock Disposition 2016-06-16 12,303 $57.42 35,385 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2016-06-15 2,231 $0.00 2,231 $26.62
Common Stock Employee Stock Option (Right to Buy) Disposition 2016-06-15 47,769 $0.00 47,769 $26.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-01-03 No 4 M Direct
0 2021-01-03 No 4 M Direct
Footnotes
  1. Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 505 shares acquired under the Issuer's employee stock purchase plan in April 2016.
  2. Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
  3. Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
  4. Weighted average sales price from sales transactions ranging from $57.19 to $57.81. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  5. The option, representing a right to purchase a total of 2,231 shares, was granted on January 3, 2011 and is fully vested.
  6. The option, representing a right to purchase a total of 47,769 shares, was granted on January 3, 2011 and is fully vested.